Impact of structured oral care strategies on oral mucositis in patients receiving 5-fluorouracil: a retrospective cohort study
Supportive Care in Cancer · 2025
DOI: 10.1007/s00520-025-10079-7 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Fernanda de Paula Eduardo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. fernanda.eduardo@einstein.br. Hauptthemen laut MEDLINE: Fluorouracil, Stomatitis, Oral Hygiene, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Themen: Mundpflege
Abstract (Originalsprache)
PURPOSE: Oral mucositis (OM) is a frequent and debilitating complication of 5-fluorouracil (5-FU)-based chemotherapy, compromising patients' quality of life and treatment adherence. This study aimed to evaluate the impact of a structured oral care strategy (OCS), including photobiomodulation (PBM), on the severity, onset, and duration of OM in patients with solid tumors receiving 5-FU-based regimens. METHODS: This single-center study included 69 patients treated between 2020 and 2022 and was retrospectively registered (Ethics Committee approval No. 5.089.912/2021). All participants received standardized OCS before and during chemotherapy, consisting of dental examination, oral hygiene instructions, infection control measures, and PBM. PBM was delivered once daily during the first two days of each 5-FU chemotherapy cycle. Associations were analyzed using Chi-square tests and odds ratios. RESULTS: All patients developed OM, predominantly grade 1 (40.6%) or grade 2 (52.2%), while only 7.2% experienced grade 3 lesions. Two PBM sessions were significantly associated with reduced onset, severity, and duration of OM, particularly among patients receiving FOLFIRINOX, for whom the risk of OM decreased 9.1-fold, and among neutropenic patients (p = 0.042). Conversely, the FOLFOX regimen was associated with earlier onset (p = 0.004) and greater severity (p = 0.026); however, two PBM sessions remained beneficial, reducing OM risk 1.35-fold. CONCLUSION: Structured OCS incorporating PBM appears to be an effective, non-invasive approach to mitigate OM severity, onset, and duration in patients undergoing 5-FU-based chemotherapy. These findings support integrating dental care and PBM into routine oncology protocols. Prospective multicenter studies are warranted to validate and standardize this strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dentistry, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. fernanda.eduardo@einstein.br.
- Department of Dentistry, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
- School of Dentistry, University of São Paulo, São Paulo, SP, Brazil.
- School of Dentistry, Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, SP, Brazil.
- Department of Oral and Maxillofacial Diagnostic Sciences, College of Dentistry, University of Florida, Gainesville, FL, USA.
Zitieren
APA
Eduardo, F. P., Ferreira, M. H., Gobbi, M. F., Bergamin, L. G., Ferreira, N. G., Migliorati, C. A., Bezinelli, L. M., & Arantes, D. C. B. (2025). Impact of structured oral care strategies on oral mucositis in patients receiving 5-fluorouracil: a retrospective cohort study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-10079-7
Vancouver
Eduardo FP, Ferreira MH, Gobbi MF, Bergamin LG, Ferreira NG, Migliorati CA, et al. Impact of structured oral care strategies on oral mucositis in patients receiving 5-fluorouracil: a retrospective cohort study. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-10079-7
BibTeX
@article{Eduardo2025,
author = {Eduardo, Fernanda de Paula and Ferreira, Mariana Henriques and Gobbi, Marcella Ferreira and Bergamin, Lívia Goron and Ferreira, Natália Guimarães and Migliorati, César Augusto and Bezinelli, Letícia Mello and Arantes, Diele Carine Barreto},
title = {Impact of structured oral care strategies on oral mucositis in patients receiving 5-fluorouracil: a retrospective cohort study},
journal = {Supportive Care in Cancer},
year = {2025},
doi = {10.1007/s00520-025-10079-7}
}
EUVIMED